GSK Asks Philippines High Court To Reconsider Imports Decision
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline Philippines asked the Philippines Supreme Court to reconsider a decision that had the effect of declaring there is no law safeguarding the country from imported drugs not registered with the government. GSK wants a new look at a recent Supreme Court ruling that the Universally Accessible Cheaper and Quality Medicines Act of 2008 allows anyone to import and use medicines without fear of being prosecuted under the Counterfeit Drugs Act, which it declared void. GSK Philippines said the court in effect nullified the Bureau of Food and Drugs as well as the counterfeit law, so it filed a motion for the court to reconsider the decision. GSK said it had a different reading of the Cheaper Medicines Act, one that says the safeguards are in place. (Click here for more